Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled furosemide versus placebo for acute cardiogenic pulmonary edema
IRCT2017101436753N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of furosemide in acute cardiogenic pulmonary edema (CPE) (2 arms), sponsored by Iran University of Medical Sciences. Started Sep 2017; status: completed.
02
Drugs
furosemide
03
Conditions
acute cardiogenic pulmonary edema (CPE)
Beyond the preview
Go deeper on IRCT2017101436753N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017101436753N1.